Serological biomarkers of tissue turnover can early identify responders to infliximab in Crohn's disease

W. T. van Haaften, J. H. Mortensen, M. L. Olesen, M. A. Karsdal, P. Olinga, A. -C. Bay-Jensen, G. Dijkstra

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S57-S57
Number of pages1
JournalJournal of Crohn's and Colitis
Publication statusPublished - 1-Feb-2017

Cite this